Cargando…

Remotely Conducted App-Based Intervention for Cardiovascular Disease and Diabetes Risk Awareness and Prevention: Single-Group Feasibility Trial

BACKGROUND: Cardiovascular disease and type 2 diabetes mellitus are two of the most prevalent chronic conditions worldwide. An unhealthy lifestyle greatly contributes to someone’s risk of developing these conditions. Mobile health is an emerging technology that can help deliver health promotion inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Buss, Vera Helen, Varnfield, Marlien, Harris, Mark, Barr, Margo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288098/
https://www.ncbi.nlm.nih.gov/pubmed/35776504
http://dx.doi.org/10.2196/38469
_version_ 1784748390567903232
author Buss, Vera Helen
Varnfield, Marlien
Harris, Mark
Barr, Margo
author_facet Buss, Vera Helen
Varnfield, Marlien
Harris, Mark
Barr, Margo
author_sort Buss, Vera Helen
collection PubMed
description BACKGROUND: Cardiovascular disease and type 2 diabetes mellitus are two of the most prevalent chronic conditions worldwide. An unhealthy lifestyle greatly contributes to someone’s risk of developing these conditions. Mobile health is an emerging technology that can help deliver health promotion interventions to the population, for example, in the form of health apps. OBJECTIVE: The aim of this study was to test the feasibility of an app-based intervention for cardiovascular and diabetes risk awareness and prevention by measuring nonusage, dropout, adherence to app use, and usability of the app over 3 months. METHODS: Participants were eligible if they were aged 45 years or older, resided in Australia, were free of cardiovascular disease and diabetes, were fluent in English, and owned a smartphone. In the beginning, participants received an email with instructions on how to install the app and a user guide. After 3 months, they received an email with an invitation to an end-of-study survey. The survey included questions about general smartphone use and the user version of the Mobile Application Rating Scale. We analyzed app-generated and survey data by using descriptive and inferential statistics as well as thematic analysis for open-text comments. RESULTS: Recruitment took place between September and October 2021. Of the 46 participants who consented to the study, 20 (44%) never used the app and 15 (33%) dropped out. The median age of the app users at baseline was 62 (IQR 56-67) years. Adherence to app use, that is, using the app at least once a week over 3 months, was 17% (8/46) of the total sample and 31% (8/26) of all app users. The mean app quality rating on the user version of the Mobile Application Rating Scale was 3.5 (SD 0.6) of 5 points. The app scored the highest for the information section and the lowest for the engagement section of the scale. CONCLUSIONS: Nonusage and dropouts were too high, and the adherence was too low to consider the intervention in its current form feasible. Potential barriers that we identified include the research team not actively engaging with participants early in the study to verify that all participants could install the app, the intervention did not involve direct contact with health care professionals, and the app did not have enough interactive features.
format Online
Article
Text
id pubmed-9288098
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-92880982022-07-17 Remotely Conducted App-Based Intervention for Cardiovascular Disease and Diabetes Risk Awareness and Prevention: Single-Group Feasibility Trial Buss, Vera Helen Varnfield, Marlien Harris, Mark Barr, Margo JMIR Hum Factors Original Paper BACKGROUND: Cardiovascular disease and type 2 diabetes mellitus are two of the most prevalent chronic conditions worldwide. An unhealthy lifestyle greatly contributes to someone’s risk of developing these conditions. Mobile health is an emerging technology that can help deliver health promotion interventions to the population, for example, in the form of health apps. OBJECTIVE: The aim of this study was to test the feasibility of an app-based intervention for cardiovascular and diabetes risk awareness and prevention by measuring nonusage, dropout, adherence to app use, and usability of the app over 3 months. METHODS: Participants were eligible if they were aged 45 years or older, resided in Australia, were free of cardiovascular disease and diabetes, were fluent in English, and owned a smartphone. In the beginning, participants received an email with instructions on how to install the app and a user guide. After 3 months, they received an email with an invitation to an end-of-study survey. The survey included questions about general smartphone use and the user version of the Mobile Application Rating Scale. We analyzed app-generated and survey data by using descriptive and inferential statistics as well as thematic analysis for open-text comments. RESULTS: Recruitment took place between September and October 2021. Of the 46 participants who consented to the study, 20 (44%) never used the app and 15 (33%) dropped out. The median age of the app users at baseline was 62 (IQR 56-67) years. Adherence to app use, that is, using the app at least once a week over 3 months, was 17% (8/46) of the total sample and 31% (8/26) of all app users. The mean app quality rating on the user version of the Mobile Application Rating Scale was 3.5 (SD 0.6) of 5 points. The app scored the highest for the information section and the lowest for the engagement section of the scale. CONCLUSIONS: Nonusage and dropouts were too high, and the adherence was too low to consider the intervention in its current form feasible. Potential barriers that we identified include the research team not actively engaging with participants early in the study to verify that all participants could install the app, the intervention did not involve direct contact with health care professionals, and the app did not have enough interactive features. JMIR Publications 2022-07-01 /pmc/articles/PMC9288098/ /pubmed/35776504 http://dx.doi.org/10.2196/38469 Text en ©Vera Helen Buss, Marlien Varnfield, Mark Harris, Margo Barr. Originally published in JMIR Human Factors (https://humanfactors.jmir.org), 01.07.2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Human Factors, is properly cited. The complete bibliographic information, a link to the original publication on https://humanfactors.jmir.org, as well as this copyright and license information must be included.
spellingShingle Original Paper
Buss, Vera Helen
Varnfield, Marlien
Harris, Mark
Barr, Margo
Remotely Conducted App-Based Intervention for Cardiovascular Disease and Diabetes Risk Awareness and Prevention: Single-Group Feasibility Trial
title Remotely Conducted App-Based Intervention for Cardiovascular Disease and Diabetes Risk Awareness and Prevention: Single-Group Feasibility Trial
title_full Remotely Conducted App-Based Intervention for Cardiovascular Disease and Diabetes Risk Awareness and Prevention: Single-Group Feasibility Trial
title_fullStr Remotely Conducted App-Based Intervention for Cardiovascular Disease and Diabetes Risk Awareness and Prevention: Single-Group Feasibility Trial
title_full_unstemmed Remotely Conducted App-Based Intervention for Cardiovascular Disease and Diabetes Risk Awareness and Prevention: Single-Group Feasibility Trial
title_short Remotely Conducted App-Based Intervention for Cardiovascular Disease and Diabetes Risk Awareness and Prevention: Single-Group Feasibility Trial
title_sort remotely conducted app-based intervention for cardiovascular disease and diabetes risk awareness and prevention: single-group feasibility trial
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288098/
https://www.ncbi.nlm.nih.gov/pubmed/35776504
http://dx.doi.org/10.2196/38469
work_keys_str_mv AT bussverahelen remotelyconductedappbasedinterventionforcardiovasculardiseaseanddiabetesriskawarenessandpreventionsinglegroupfeasibilitytrial
AT varnfieldmarlien remotelyconductedappbasedinterventionforcardiovasculardiseaseanddiabetesriskawarenessandpreventionsinglegroupfeasibilitytrial
AT harrismark remotelyconductedappbasedinterventionforcardiovasculardiseaseanddiabetesriskawarenessandpreventionsinglegroupfeasibilitytrial
AT barrmargo remotelyconductedappbasedinterventionforcardiovasculardiseaseanddiabetesriskawarenessandpreventionsinglegroupfeasibilitytrial